Check out your Company Bowl for anonymous work chats.
“[Amplity Health] is innovative, the offering we have is quite unique, and it will be very different from any other company you will get the opportunity to work with.” Meet Nick Willhoft, PhD, Head of Medical Communications at Amplity Health. Want to know more about what Amplity Health can offer you? Hear from some of our other team members and explore our current job opportunities. https://bit.ly/3GvAHAB #WeAreAmplity #AmplityHealthCareers
Oncology Practice Management (OPM) seeks to offer process solutions for all members of the cancer care team. Connect with Joseph Haddad today to learn how your organization can leverage OPM to reach and engage with community physicians and practice managers. #oncology #oncologypractice #practicemanagers #cancercareteam
We are thrilled to share that we will be participating at Pharma USA 2024 as a Platinum sponsor. Join us and 1,200+ industry pioneers here: https://bit.ly/3SuhJ4l Our very own Christina DiBiase will be joining the keynote panel discussing how to unleash pharma’s modernized growth plan by leveraging digital and tech innovation. Don’t miss out! #REpharmaUSA
Biosimilar interchangeability seems to have been acknowledged and accepted by payers as a relevant differentiator for formulary inclusion and placement. This is despite the FDA’s continued assurance that interchangeability does not indicate a superior product. In a recent article featured in Life Science Leader magazine, co-author Nikolina Janakievski, PharmD, Amplity Health’s Associate Director of Market Access, highlights the impact of interchangeability on Humira, as well as the FDA’s current efforts to minimize the significance of this designation to stakeholders in advance of dispensing medication. Read the article https://bit.ly/3HhRWWk
Hailed as a “game changer” by industry stakeholders, Amplity Health’s new Survey by AskX platform employs first-of-its-kind AI-powered capabilities that allow leadership to create customized field surveys and explore results using advanced application of generative AI on free-text responses. Learn how Survey by AskX can help your teams excel in 2024. https://bit.ly/3TYrcSA
We’re defining the care team engagement model of the future and delivering on it today. Our engagement starts with an existing or a created community. Talk to us about how we overcome the common barriers preventing our pharma clients from effectively reaching their intended audiences on their own.
We often hear from companies a year into launch saying they wish they had deployed an FRM team immediately at launch. They recognize that they left business on the table. More importantly, patients who needed and deserved the product during that year did not get it. Read our article for the three considerations pharma must consider when deploying FRMs at launch: https://lnkd.in/gDfTskWJ
Compliance should not hinder profitability but should be a means to ensure it. If you’re a small to medium-sized pharma company launching a product for the first time, you need a compliance partner who deeply understands both the pharma industry and your company's unique business goals. Amplity’s Director of Compliance, Keysha Bradford, can help. Start by reading her latest article on how to conduct a readiness assessment, identify commercial risks, and establish a compliance program that aligns with the OIG's recommendations: https://lnkd.in/eFdVyFqx. Then contact Keysha to learn how and why we’re best suited to help you customize your program to your specific business needs: keysha.bradford@amplity.com
Research reveals that ~64% of potentially eligible patients are not benefiting from precision oncology therapies. As a solutions provider committed to improving the landscape of personalized medicine, we recognize the urgency of addressing clinical practice gaps. Our newest article details the challenges pharmaceutical companies commonly face when integrating predictive biomarker testing into clinical care. Read the article here: https://lnkd.in/e3Vc2zUF
The continuum from published evidence to field team resources seems obvious and intuitive, yet it breaks down all too often. We have the success prescription for pharma’s field #medical teams’ challenges. Contact us to learn how we can help redefine the odyssey into a manageable continuum.
